CN108402228A - A kind of black tea Cortex Magnoliae Officinalis tablet - Google Patents
A kind of black tea Cortex Magnoliae Officinalis tablet Download PDFInfo
- Publication number
- CN108402228A CN108402228A CN201810545447.5A CN201810545447A CN108402228A CN 108402228 A CN108402228 A CN 108402228A CN 201810545447 A CN201810545447 A CN 201810545447A CN 108402228 A CN108402228 A CN 108402228A
- Authority
- CN
- China
- Prior art keywords
- black tea
- magnoliae officinalis
- cortex magnoliae
- parts
- extract powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a kind of black tea Cortex Magnoliae Officinalis tablets, including gulp down piece and lozenge, it is characterised in that：A, the constituent for gulping down piece includes black tea Cortex Magnoliae Officinalis extract powder and tableting aid, and the weight proportion for gulping down piece constituent is：Black tea Cortex Magnoliae Officinalis extract powder is 2~50 parts, tableting aid is 50~98 parts；B, the constituent of the lozenge includes black tea Cortex Magnoliae Officinalis extract powder, tableting aid and sweetener, and the weight proportion of lozenge constituent is：Black tea Cortex Magnoliae Officinalis extract powder is 2~50 parts, tableting aid is 58~89.98 parts, sweetener is 0.02~2 part.The present invention uses black tea, Cortex Magnoliae Officinalis, arhat first sweetener, microcrystalline cellulose for raw material, refinement is mixed and made into black tea Cortex Magnoliae Officinalis tablet, the beneficiating ingredient being extracted in black tea magnolia obovata, it complements each other with momordica grosvenori sweetening agent, microcrystalline cellulose, has higher nutritive value and health value, easy to carry, it is convenient, in good taste, heat is low, hypoglycemic effect.
Description
Technical field
The present invention relates to health products manufacture fields, and in particular to a kind of black tea Cortex Magnoliae Officinalis tablet.
Background technology
Anhua black tea category black tea, gains the name because originating from Hunan China Anhua County, using the big of the domestic mountain area plantation in Anhua
Leaf kind tealeaves by finishing, rubbing, pile fermentation, bakes the techniques such as dry and is processed into Dark Green Tea and using it as feed purification（Including
Fermentation and ageing naturally after artificial）It forms, has effects that oxidation-resisting and caducity, anticancer become；Anhua black tea principal item has " three
Point ", " three bricks ", " a roll ", tricuspid tea are also known as Hunan point tea, refer to day point, tribute point, raw point；" three bricks " refers to Fu bricks, black brick and flower
Brick；" a roll " refers to Hua-juan tea, is now referred to as Anhua thousand tael tea.
Just there is the history of " curing the disease with tea " in China from ancient times, and ancient times are civil using old tea treatment diabetes, dysentery, cold etc.
Record it is a lot of, in the research of black tea function, it was demonstrated that black tea at least nine big health maintenance effect：Complementary diets nutrition；Aid digestion,
Solve greasy, suitable stomach；Lipid-loweringing, weight-reducing, softening human vas, prevention of cardiovascular disease；Anti-oxidant, anti-aging, promotes longevity；
Anticancer, antimutation；Improve carbohydate metabolism, it is hypoglycemic, prevent diabetes；Sterilization, anti-inflammatory；Diuresis removing toxic substances reduces tobacco and wine murder by poisoning.
Cortex Magnoliae Officinalis is conventional Chinese medicine, from the drying dry hide of Magnoliaceae magnolia Cortex Magnoliae Officinalis and Magnolia bilola, branch skin and
Root skin, main product in Hunan, Sichuan, Hubei, Zhejiang, Fujian and Anhui and other places, have remove dampness by means of aromatics, gas consumption product, eliminating dampness except full,
The effect of relieving asthma, cures mainly the diseases such as stagnation of QI due to dyspepsia, abdominal distention constipation, damp retention in middle-jiao, abdominal swelling and diarrhea, phlegm stops up the circulation of vital energy in the wrong direction, chest full of cough
Disease has Cortex Magnoliae Officinalis to be used as medicine in many commonly-used prescription and Chinese patent medicine preparation.
Invention content
It is in good taste, heat is low, the black tea of nutrition health care again is thick it is an object of the invention to provide a kind of carrying, convenient to take
Plain tablet.
The purpose of the present invention can be achieved through the following technical solutions：A kind of black tea Cortex Magnoliae Officinalis tablet, including gulp down piece and contain
Piece, it is characterised in that：
A, the constituent for gulping down piece includes black tea Cortex Magnoliae Officinalis extract powder and tableting aid, and the weight proportion for gulping down piece constituent is：It is black
Tea Cortex Magnoliae Officinalis extract powder is 2~50 parts, tableting aid is 50~98 parts；
B, the constituent of the lozenge includes black tea Cortex Magnoliae Officinalis extract powder, tableting aid and sweetener, and the weight of lozenge constituent is matched
Than for：Black tea Cortex Magnoliae Officinalis extract powder is 2~50 parts, tableting aid is 48~97.98 parts, sweetener is 0.02~2 part.
The tableting aid is microcrystalline cellulose or starch or dextrin.
The sweetener is Siraitia grosvenorii natural sweetener.
The processing technology of the black tea Cortex Magnoliae Officinalis extract powder is as follows：
A, black tea, the extraction of Cortex Magnoliae Officinalis percolation or boiling extraction：By black tea：Cortex Magnoliae Officinalis：The weight ratio of water presses 1~10：1~
10：80~98, water temperature is 50~96 DEG C, extracts 1~3 hour, obtains black tea Cortex Magnoliae Officinalis solution；
B, three-stage filtration：Black tea Cortex Magnoliae Officinalis solution is passed sequentially through in 20 mesh coarse filtration, 200-400 mesh after filter, flannelette fine filtering, it will be thin
Solution after filter is cooled to 1-20 DEG C, and precipitation removes sediment, solution after must cooling down；
C, cream powder processed is concentrated：Solution is by the molecular sieve of 1-10 ten thousand molecular weight after cooling, and centrifugal thin-film is dense at 30~90 DEG C
Contracting, it is 3 to obtain solid-to-liquid ratio：7 concentrate, then black tea Cortex Magnoliae Officinalis extract powder is obtained after microwave low-temperature drying.
Use the processing technology of above-mentioned formula production black tea Cortex Magnoliae Officinalis tablet for：
1, it mixes：By black tea Cortex Magnoliae Officinalis extract powder：2~50 parts of tableting aid weight part ratio：50~98 parts be uniformly mixed or will be black
Tea Cortex Magnoliae Officinalis extract powder：Tableting aid：2~50 parts of sweetener weight part ratio：48~97.98 parts：0.02~2 part is uniformly mixed,
Obtain compound；
2, tabletting：Compound is tabletted to get black tea Cortex Magnoliae Officinalis tablet through conventional tablet press machine.
Beneficial effects of the present invention：The present invention uses black tea, Cortex Magnoliae Officinalis, arhat first sweetener, microcrystalline cellulose for raw material,
Refinement is mixed and made into black tea Cortex Magnoliae Officinalis tablet, and the beneficiating ingredient being extracted in black tea magnolia obovata is fine with momordica grosvenori sweetening agent, crystallite
Dimension element complements each other, and has higher nutritive value and health value, and easy to carry, convenient, in good taste, heat is low,
Hypoglycemic effect.
Black tea is also refreshed oneself with pure and fresh, is helped digest in addition to quench one's thirst of promoting the production of body fluid, and antidiarrheal is sterilized, and reduces by three high (hyperglycemia, height
Blood fat, hypertension) and other effects.
Cortex Magnoliae Officinalis promotes outside stomach health, in addition to having killing enteric bacteria wherein being same containing magnolol and honokiol
Enantiomers, the two are the Antibacterial Constituents of conventional Chinese medicine Cortex Magnoliae Officinalis, while being also the leading indicator of magnolia medicament quality control
Ingredient, both document reports also have anti-inflammatory, antianxiety, antidepression, antitumor, anti-aging and cardiac muscle other than antibacterial action
Protective effect；In addition, also apparent, lasting central is of flaccid muscles and Central nervous depressant；There is pharmacodynamics in the recent period
Research confirms that magnolol and honokiol also show hypoglycemic activity.
Microcrystalline cellulose is a kind of important dietary cellulosic and ideal food supplement, is mainly made here dilute
Agent and adhesive are released, also there is certain lubrication and calving disaggregation.
Momordica grosvenori sweetening agent is high sweetener essence of a pure in mouth feel without any miscellaneous taste, pure in mouth feel, without any
Peculiar smell or bitter taste, sweetness profile curve are almost overlapped with sucrose, have good stability and dissolubility, from acidity to alkali
Property can be highly stable holding sugariness, and mouthfeel is not any change, energy value almost without, for diabetes patient with it is cardiovascular
Disease and the elderly use.
Specific implementation mode
The present invention and its specific implementation mode are described in further detail with reference to embodiment.
The present invention includes gulping down piece and lozenge, it is characterised in that：
A, the constituent for gulping down piece includes black tea Cortex Magnoliae Officinalis extract powder and tableting aid, and the weight proportion for gulping down piece constituent is：It is black
Tea Cortex Magnoliae Officinalis extract powder is 2~50 parts, tableting aid is 50~98 parts；
B, the constituent of the lozenge includes black tea Cortex Magnoliae Officinalis extract powder, tableting aid and sweetener, and the weight of lozenge constituent is matched
Than for：Black tea Cortex Magnoliae Officinalis extract powder is 2~50 parts, tableting aid is 48~97.98 parts, sweetener is 0.02~2 part.
The tableting aid is microcrystalline cellulose or starch or dextrin.
The sweetener is Siraitia grosvenorii natural sweetener.
The processing technology of the black tea Cortex Magnoliae Officinalis extract powder is as follows：
A, black tea, the extraction of Cortex Magnoliae Officinalis percolation or boiling extraction：By black tea：Cortex Magnoliae Officinalis：The weight ratio of water presses 1~10：1~
10：80~98, water temperature is 50~96 DEG C, extracts 1~3 hour, obtains black tea Cortex Magnoliae Officinalis solution；
B, three-stage filtration：Black tea Cortex Magnoliae Officinalis solution is passed sequentially through in 20 mesh coarse filtration, 200-400 mesh after filter, flannelette fine filtering, it will be thin
Solution after filter is cooled to 1-20 DEG C, and precipitation removes sediment, solution after must cooling down；
C, cream powder processed is concentrated：Solution is by the molecular sieve of 1-10 ten thousand molecular weight after cooling, and centrifugal thin-film is dense at 30~90 DEG C
Contracting, it is 3 to obtain solid-to-liquid ratio：7 concentrate, then black tea Cortex Magnoliae Officinalis extract powder is obtained after microwave low-temperature drying.
The processing technology of black tea Cortex Magnoliae Officinalis tablet is：
1, it mixes：Weight proportion by each constituent is：Black tea Cortex Magnoliae Officinalis extract powder is 2~50 parts, tableting aid is 50~98 parts
It is uniformly mixed or 0.02~2 part of 2~50 parts of black tea Cortex Magnoliae Officinalis extract powder, 48~97.98 parts of tableting aid, sweetener mixing is equal
It is even, obtain compound；
2, tabletting：Compound is tabletted to get swallowing or buccal black tea Cortex Magnoliae Officinalis tablet through conventional tablet press machine.
The percolation is that the tealeaves that will moderately crush is set in percolator, constantly adds solvent by top, solvent oozed tea
The method that tea component is leached during leaf sulfate layer flows downhill is dynamic.
Centrifugal thin-film concentration is completed in centrifugal film evaporator, the evaporator be used for by liquid distribution at
Uniform liquid film and be evaporated or concentrate, have evaporation time short, it is only necessary to evaporation process can be completed within even less than 1 second 1 second,
To can guarantee that extract maintains original state not change.
The microwave low-temperature drying is completed in microwave low-temperature drying machine, and microwave drying is different from traditional drying mode,
Its heat transfer direction is identical as moisture diffusion direction, compared with traditional drying mode, production effect fast, energy saving with rate of drying
Rate height, clean manufacturing, easily realizes the advantages that automation control and raising product quality at uniform drying.
Mesh number is exactly hole count, be exactly per square inch on number of perforations, mesh number is bigger, and aperture is smaller, such as：20 mesh holes
Diameter is 830 microns, and 200 mesh apertures are 75 microns, and 400 mesh apertures are 38 microns.
Starch is the polysaccharide constituted as unit of glucose, and carbohydrate the abundantest, starch are in human diet
What glucose molecule was polymerized, it is that the most common storage form of carbohydrate, general formula are (C in cell6H10O5) n, water
It is maltose to solve the disaccharides stage, and chemical formula is C12H22O11, monosaccharide is obtained after complete hydrolysis（Glucose）, chemical formula is
C6H12O6 。
Dextrin is to make raw material with each kind of starch such as corn, rice etc., controls hydrolysis through enzyme method technique low degree, carries
Pure, a kind of carbohydrate made of drying has sugariness low, and dissolubility is good, is not easy the moisture absorption, and stability is good, it is difficult to rotten
Characteristic, the product have thickening property strong, and carrier-mediated good, Fermented is small, nonhygroscopic, free from extraneous odour, easy to digest, low-heat, low sugariness etc.
Feature；Dextrin contains a large amount of polysaccharide, in addition also containing the trace element and minerals beneficial to human body such as calcium, iron, and energy
Promote the metabolism of human normal.
The embodiment of the present invention is given below.
Embodiment 1
1, it mixes：97 parts of 3 parts of black tea Cortex Magnoliae Officinalis extract powder and microcrystalline cellulose are uniformly mixed to obtain compound；
2, tabletting：Compound is tabletted to get swallowing black tea Cortex Magnoliae Officinalis tablet through conventional tablet press machine.
The weight of the black tea Cortex Magnoliae Officinalis tablet is 0.5 gram.
Embodiment 2
1, it mixes：90 parts of 10 parts of black tea Cortex Magnoliae Officinalis extract powder and dextrin are uniformly mixed to obtain compound；
2, tabletting：Compound is tabletted to get swallowing black tea Cortex Magnoliae Officinalis tablet through conventional tablet press machine.
The weight of the black tea Cortex Magnoliae Officinalis tablet is 0.5 gram.
Embodiment 3
1, it mixes：80 parts of 20 parts of black tea Cortex Magnoliae Officinalis extract powder and dextrin are uniformly mixed to obtain compound；
2, tabletting：Compound is tabletted to get swallowing black tea Cortex Magnoliae Officinalis tablet through conventional tablet press machine.
The weight of the black tea Cortex Magnoliae Officinalis tablet is 0.5 gram.
Embodiment 4
1, it mixes：0.03 part of 3 parts of black tea Cortex Magnoliae Officinalis extract powder, 96.97 parts of starch and Siraitia grosvenorii natural sweetener are uniformly mixed, obtained
Compound；
2, tabletting：Compound is tabletted to get buccal black tea Cortex Magnoliae Officinalis tablet through conventional tablet press machine.
The weight of the black tea Cortex Magnoliae Officinalis tablet is 1 gram.
Embodiment 5
1, it mixes：By 0.03 part of 4 parts of black tea Cortex Magnoliae Officinalis extract powder, 95.97 parts of microcrystalline cellulose and Siraitia grosvenorii natural sweetener mixing
Uniformly, compound is obtained；
2, tabletting：Compound is tabletted to get buccal black tea Cortex Magnoliae Officinalis tablet through conventional tablet press machine.
The weight of the black tea Cortex Magnoliae Officinalis tablet is 0.75 gram.
Embodiment 6
1, it mixes：By 0.04 part of 5 parts of black tea Cortex Magnoliae Officinalis extract powder, 94.96 parts of microcrystalline cellulose and Siraitia grosvenorii natural sweetener mixing
Uniformly, compound is obtained；
2, tabletting：Compound is tabletted to get buccal black tea Cortex Magnoliae Officinalis tablet through conventional tablet press machine.
The weight of the black tea Cortex Magnoliae Officinalis tablet is 0.75 gram.
Claims (3)
1. a kind of black tea Cortex Magnoliae Officinalis tablet, including gulp down piece and lozenge, it is characterised in that：
A, the constituent for gulping down piece includes black tea Cortex Magnoliae Officinalis extract powder and tableting aid, and the weight proportion for gulping down piece constituent is：It is black
Tea Cortex Magnoliae Officinalis extract powder is 2~50 parts, tableting aid is 50~98 parts；
B, the constituent of the lozenge includes black tea Cortex Magnoliae Officinalis extract powder, tableting aid and sweetener, and the weight of lozenge constituent is matched
Than for：Black tea Cortex Magnoliae Officinalis extract powder is 2~50 parts, tableting aid is 48~97.98 parts, sweetener is 0.02~2 part.
2. by a kind of black tea Cortex Magnoliae Officinalis tablet described in claim 1, it is characterised in that the tableting aid is microcrystalline cellulose or shallow lake
Powder or dextrin.
3. by a kind of black tea Cortex Magnoliae Officinalis tablet described in claim 2, it is characterised in that the sweetener is Siraitia grosvenorii natural sweetener.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810545447.5A CN108402228A (en) | 2018-05-31 | 2018-05-31 | A kind of black tea Cortex Magnoliae Officinalis tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810545447.5A CN108402228A (en) | 2018-05-31 | 2018-05-31 | A kind of black tea Cortex Magnoliae Officinalis tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108402228A true CN108402228A (en) | 2018-08-17 |
Family
ID=63140952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810545447.5A Pending CN108402228A (en) | 2018-05-31 | 2018-05-31 | A kind of black tea Cortex Magnoliae Officinalis tablet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108402228A (en) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1155386A (en) * | 1996-12-11 | 1997-07-30 | 樊华轩 | Tea flakes and their production |
| CN1653920A (en) * | 2004-02-11 | 2005-08-17 | 白峰 | Tea buccal tablet and its manufacturing method |
| CN103828965A (en) * | 2014-02-28 | 2014-06-04 | 徐星航 | Compound black tea granules and preparation method thereof |
| CN104855636A (en) * | 2015-05-27 | 2015-08-26 | 北京笑傲天宫生物科技有限公司 | Black tea extract and oral solid instant preparation thereof |
| CN105028864A (en) * | 2015-06-30 | 2015-11-11 | 朱丹 | Dark tea extract buccal tablets and preparation method thereof |
| CN105285214A (en) * | 2015-11-20 | 2016-02-03 | 贺志弘 | Dark tea composition with effect on clearing and nourishing throat and preparation method |
| CN105532991A (en) * | 2016-02-01 | 2016-05-04 | 北京三奇本草科技有限公司 | Composite dark green tea with functions of maintaining beauty and caring skin and preparation method thereof |
| CN106538740A (en) * | 2016-11-18 | 2017-03-29 | 苏州碧水缘茶叶有限公司 | A kind of postfermented tea buccal tablet and preparation method thereof |
| CN106804816A (en) * | 2017-01-16 | 2017-06-09 | 广州大浦金医药科技有限公司 | Tea buccal tablet and preparation method thereof |
-
2018
- 2018-05-31 CN CN201810545447.5A patent/CN108402228A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1155386A (en) * | 1996-12-11 | 1997-07-30 | 樊华轩 | Tea flakes and their production |
| CN1653920A (en) * | 2004-02-11 | 2005-08-17 | 白峰 | Tea buccal tablet and its manufacturing method |
| CN103828965A (en) * | 2014-02-28 | 2014-06-04 | 徐星航 | Compound black tea granules and preparation method thereof |
| CN104855636A (en) * | 2015-05-27 | 2015-08-26 | 北京笑傲天宫生物科技有限公司 | Black tea extract and oral solid instant preparation thereof |
| CN105028864A (en) * | 2015-06-30 | 2015-11-11 | 朱丹 | Dark tea extract buccal tablets and preparation method thereof |
| CN105285214A (en) * | 2015-11-20 | 2016-02-03 | 贺志弘 | Dark tea composition with effect on clearing and nourishing throat and preparation method |
| CN105532991A (en) * | 2016-02-01 | 2016-05-04 | 北京三奇本草科技有限公司 | Composite dark green tea with functions of maintaining beauty and caring skin and preparation method thereof |
| CN106538740A (en) * | 2016-11-18 | 2017-03-29 | 苏州碧水缘茶叶有限公司 | A kind of postfermented tea buccal tablet and preparation method thereof |
| CN106804816A (en) * | 2017-01-16 | 2017-06-09 | 广州大浦金医药科技有限公司 | Tea buccal tablet and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 梁浩荣: "《妇科调经良方》", 31 May 2016, 青岛出版社 * |
| 黑茶二两拨千金: "厚朴花开茶更香", 《百度 HTTP://BLOG.SINA.COM.CN/S/BLOG_691064750102VVQO.HTML》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103146560B (en) | Health-care vinegar and preparation method thereof | |
| CN101288483B (en) | Preparation method of ginger and jujube granule | |
| CN101467569A (en) | Bitter melon tea and preparation method thereof | |
| CN108112973A (en) | A kind of auxiliary lower hyperlipidemia, hypertension, hyperglycemia composition and preparation method thereof | |
| CN106107345A (en) | A kind of method of Semen Ziziphi Spinosae fermentation preparation enzyme beverage | |
| CN102894364B (en) | Preparation method of balsam pear/green tea sugar-reducing buccal tablets | |
| CN102687890A (en) | Plant beverage with effect of reducing blood sugar, and preparation method and application thereof | |
| CN103372047A (en) | Eucommia bark buccal tablets and preparation method thereof | |
| CN104146247A (en) | Preparation method of momordica grosvenori syrup | |
| CN106261409A (en) | The manufacture method of Radix Tinosporae Fructus Crataegi lactic acid beverage | |
| CN103343078B (en) | Production process of golden stichopus japonicus health-care yellow wine | |
| CN105831318A (en) | Polypeptide tea for blood glucose reduction and manufacturing method of polypeptide tea | |
| CN108402228A (en) | A kind of black tea Cortex Magnoliae Officinalis tablet | |
| CN108260745A (en) | One kind moistens the lung and relieve the cough fruit vinegar beverage and preparation method thereof | |
| CN1943448A (en) | Bamboo juice and ginkgo drink and its producing method | |
| CN108157545A (en) | A kind of guava leaf liquid beverage and preparation method thereof | |
| CN108741046B (en) | Tamarind crystal beer cake and preparation method thereof | |
| CN107372947B (en) | Tea bag type blood sugar reducing tea and preparation method thereof | |
| CN106165815A (en) | A kind of dispersing lung-QI and dissipating phlegm antiasthmatic-antitussive beverage and preparation processing method | |
| CN104920723A (en) | Tea drink for joint treatment of diabetes and making method thereof | |
| CN112168944A (en) | Traditional Chinese medicine composition and extract for preventing new coronary pneumonia, and preparation method and application thereof | |
| CN105454750A (en) | Preparation method of sesame seed and honey syrup | |
| CN107279650A (en) | A kind of preventing phlegm from forming and stopping coughing, drop triglyceride solid beverage | |
| CN107467295A (en) | One kind preventing and treating sphagitis Chinese herbal medicine health care cold tea and preparation method thereof | |
| CN108653476A (en) | One kind is reduced internal heat anti-inflammatory, pharynx-clearing throat-benefiting Tea containing traditional Chinese medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180817 |